Evidence map›Paper›PMID 31174021›Full record

ArticleNeoplasia (New York, N.Y.)2019

Induced Chromosomal Aneuploidy Results in Global and Consistent Deregulation of the Transcriptome of Cancer Cells.

Darawalee Wangsa, Rüdiger Braun, Christina H Stuelten, Markus Brown, Kerry M Bauer, Georg Emons, Leigh A Weston, Yue Hu, Howard H Yang, Maria Vila-Casadesús and 7 more

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Darawalee WangsaSection of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Rüdiger BraunSection of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Christina H StueltenLaboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Markus BrownSection of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Kerry M BauerDepartment of Chemistry and Biochemistry and the Comprehensive Cancer Center, The Ohio State University, Columbus, OH.
Georg EmonsSection of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Leigh A WestonDepartment of Chemistry and Biochemistry and the Comprehensive Cancer Center, The Ohio State University, Columbus, OH.
Yue HuSection of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Howard H YangHigh Dimension Data Analysis Group, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Maria Vila-CasadesúsLaboratory of Gastrointestinal and Pancreatic Oncology, Institut D'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic of Barcelona, CIBERehd, Barcelona, Spain.
Maxwell P LeeHigh Dimension Data Analysis Group, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Philip BrauerSection of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Lidia WarnerSection of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Madhvi UpenderSection of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Amanda B HummonDepartment of Chemistry and Biochemistry and the Comprehensive Cancer Center, The Ohio State University, Columbus, OH.
Jordi CampsLaboratory of Gastrointestinal and Pancreatic Oncology, Institut D'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic of Barcelona, CIBERehd, Barcelona, Spain. Electronic address: jcamps@clinic.ub.es.
Thomas RiedSection of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: riedt@mail.nih.gov.
National Cancer Institute · USThe Ohio State University · USCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESNational Institutes of Health · USCenter for Cancer Research · US

Funding

Integrated analyses of genetics, epigenetics, and gene expressionZIHBC011703 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEE, MAXWELL · 2016 to 2025
$10.9M
6 · The paper itself

Abstract

Chromosomal aneuploidy is a defining feature of epithelial cancers. The pattern of aneuploidies is cancer-type specific. For instance, the gain of chromosome 13 occurs almost exclusively in colorectal cancer. We used microcell-mediated chromosome transfer to generate gains of chromosome 13 in the diploid human colorectal cancer cell line DLD-1. Extra copies of chromosome 13 resulted in a significant and reproducible up-regulation of transcript levels of genes on chromosome 13 (P = .0004, FDR = 0.01) and a genome-wide transcriptional deregulation in all 8 independent clones generated. Genes contained in two clusters were particularly affected: the first cluster on cytoband 13q13 contained 7 highly up-regulated genes (NBEA, MAB21L1, DCLK1, SOHLH2, CCDC169, SPG20 and CCNA1, P = .0003) in all clones. A second cluster was located on 13q32.1 and contained five upregulated genes (ABCC4, CLDN10, DZIP1, DNAJC3 and UGGT2, P = .003). One gene, RASL11A, localized on chromosome band 13q12.2, escaped the copy number-induced overexpression and was reproducibly and significantly down-regulated on the mRNA and protein level (P = .0001, FDR = 0.002). RASL11A expression levels were also lower in primary colorectal tumors as compared to matched normal mucosa (P = .0001, FDR = 0.0001. Overexpression of RASL11A increases cell proliferation and anchorage independent growth while decreasing cell migration in +13 clones. In summary, we observed a strict correlation of genomic copy number and resident gene expression levels, and aneuploidy dependent consistent genome-wide transcriptional deregulation.

Indexed as

AneuploidyChromosomesColorectal NeoplasmsComparative Genomic HybridizationDNA Copy Number VariationsGene Expression Regulation, NeoplasticHumansMonomeric GTP-Binding ProteinsNeoplasm ProteinsTranscriptional ActivationTranscriptomeMonomeric GTP-Binding ProteinsNeoplasm ProteinsRASL11A protein, human

Identifiers

PMID31174021
PMCPMC6551473
OpenAlexW2948150874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.